Andrea Loewen, SVP, Global Regulatory Affairs at REATA PHARMACEUTICALS INC (RETA), sold 7,166 shares at $86.26 ($616K) on 2023-05-12, disclosed to the SEC on 2023-05-16.
Open-market sale of $616k RETA by SVP, Global Regulatory Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.26 | 6,750 | $582K | 94.5% |
| 2 | $84.71 | 103 | $9K | 1.4% |
| 3 | $81.02 | 313 | $25K | 4.1% |
| Total | $86.01 avg | 7,166 | $616K | 100% |
| Filing → |
| RETA | SELL | 2023-03-06 | $301K | — | Filing → |